SEC Form 4 · accession 0001246360-17-002020
NxStage Medical, Inc. · NXTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Heyward R Donigan
Director
Period of report
Apr 20, 2017
Accepted (ET)
May 26, 2017 · 3:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001333170
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 20, 2017 | M | 3,582 | $21.73 | A | 3,582 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $21.73 | Apr 20, 2017 | M | 3,582 | D | Aug 15, 2016 | Jul 14, 2023 | Common Stock | 3,582 | 10,784 | D |
| Stock Option (Right to Buy)F1 | $22.78 | May 25, 2017 | A | 15,643 | A | Jun 25, 2017 | May 24, 2024 | Common Stock | 15,643 | 15,643 | D |
Explanation of responses
- F1The stock option becomes exercisable in 12 equal monthly installments beginning June 25, 2017.